Strong R, et al. Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an alpha-glucosidase inhibitor or a Nrf2-inducer. Aging Cell. 2016;15(5):872–84.
Article CAS PubMed PubMed Central Google Scholar
Harrison DE, et al. Acarbose, 17-alpha-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males. Aging Cell. 2014;13(2):273–82.
Article CAS PubMed Google Scholar
Harrison DE, et al. 17-a-estradiol late in life extends lifespan in aging UM-HET3 male mice; nicotinamide riboside and three other drugs do not affect lifespan in either sex. Aging Cell. 2021;20(5):e13328.
Article CAS PubMed PubMed Central Google Scholar
Turturro A, et al. Growth curves and survival characteristics of the animals used in the Biomarkers of Aging Program. J Gerontol A Biol Sci Med Sci. 1999;54(11):B492-501.
Article CAS PubMed Google Scholar
Stout MB, et al. 17alpha-Estradiol Alleviates Age-related Metabolic and Inflammatory Dysfunction in Male Mice Without Inducing Feminization. J Gerontol A Biol Sci Med Sci. 2017;72(1):3–15.
Article CAS PubMed Google Scholar
Steyn FJ, et al. 17alpha-estradiol acts through hypothalamic pro-opiomelanocortin expressing neurons to reduce feeding behavior. Aging Cell. 2018;17(1):e12703.
Mann SN, et al. Health benefits attributed to 17alpha-estradiol, a lifespan-extending compound, are mediated through estrogen receptor alpha. Elife. 2020;9:e59616.
Miller BF, et al. Short-term Calorie Restriction and 17alpha-Estradiol Administration Elicit Divergent Effects on Proteostatic Processes and Protein Content in Metabolically Active Tissues. J Gerontol A Biol Sci Med Sci. 2020;75(5):849–57.
Article CAS PubMed Google Scholar
Sidhom S, et al. 17alpha-Estradiol Modulates IGF1 and Hepatic Gene Expression in a Sex-Specific Manner. J Gerontol A Biol Sci Med Sci. 2021;76(5):778–85.
Article CAS PubMed Google Scholar
Mondal SA, et al. Metabolic benefits of 17alpha-estradiol in liver are partially mediated by ERbeta in male mice. Sci Rep. 2023;13(1):9841.
Article CAS PubMed PubMed Central Google Scholar
Bubak MP, et al. 17alpha-Estradiol alleviates high-fat diet-induced inflammatory and metabolic dysfunction in skeletal muscle of male and female mice. Am J Physiol Endocrinol Metab. 2024;326(3):E226–44.
Article CAS PubMed Google Scholar
Sathiaseelan R, et al. A genetically heterogeneous rat model with divergent mitochondrial genomes. J Gerontol A Biol Sci Med Sci. 2023;78(5):771–9.
Ali Mondal S, et al. 17alpha-estradiol, a lifespan-extending compound, attenuates liver fibrosis by modulating collagen turnover rates in male mice. Am J Physiol Endocrinol Metab. 2023;324(2):E120–34.
Garratt M, et al. Sex differences in lifespan extension with acarbose and 17-alpha estradiol: gonadal hormones underlie male-specific improvements in glucose tolerance and mTORC2 signaling. Aging Cell. 2017;16(6):1256–66.
Article CAS PubMed PubMed Central Google Scholar
Garratt M, et al. Male lifespan extension with 17-alpha estradiol is linked to a sex-specific metabolomic response modulated by gonadal hormones in mice. Aging Cell. 2018;17(4):e12786.
Article PubMed PubMed Central Google Scholar
Garratt M, et al. 17-alpha estradiol ameliorates age-associated sarcopenia and improves late-life physical function in male mice but not in females or castrated males. Aging Cell. 2019;18(2):e12920.
Article PubMed PubMed Central Google Scholar
Garratt M, Stout MB. Hormone actions controlling sex-specific life-extension. Aging (Albany NY). 2018;10(3):293–4.
Debarba LK, et al. 17-alpha-Estradiol Has Sex-Specific Effects on Neuroinflammation That Are Partly Reversed by Gonadectomy. J Gerontol A Biol Sci Med Sci. 2022;77(1):66–74.
Article CAS PubMed Google Scholar
Camon C, et al. Systemic metabolic benefits of 17alpha-estradiol are not exclusively mediated by ERalpha in glutamatergic or GABAergic neurons. Geroscience. 2024. https://doi.org/10.1007/s11357-024-01192-2.
Isola JVV, et al. 17α-estradiol does not adversely affect sperm parameters or fertility in male mice: implications for reproduction-longevity trade-offs. Geroscience. 2023;45(4):2109–20.
Moos WH, et al. Review of the Effects of 17 alpha-Estradiol in Humans: A Less Feminizing Estrogen With Neuroprotective Potential. Drug Development Research. 2009;70(1):1–21.
Colman RJ. Non-human primates as a model for aging. Biochim Biophys Acta Mol Basis Dis. 2018;1864(9 Pt A):2733–41.
Article CAS PubMed Google Scholar
Stout MB, et al. Assessing tolerability and physiological responses to 17alpha-estradiol administration in male rhesus macaques. Geroscience. 2023;45(4):2337–49.
Article CAS PubMed PubMed Central Google Scholar
Salmon AB. Moving toward “common” use of the marmoset as a non-human primate aging model. Pathobiol Aging Age Relat Dis. 2016;6:32758.
Marmoset Genome S, Analysis C. The common marmoset genome provides insight into primate biology and evolution. Nat Genet. 2014;46(8):850–7.
Tardif SD, et al. The marmoset as a model of aging and age-related diseases. ILAR J. 2011;52(1):54–65.
Article CAS PubMed Google Scholar
Ross CN, et al. Aging Phenotypes of Common Marmosets (Callithrix jacchus). J Aging Res. 2012;2012:567143.
Article PubMed PubMed Central Google Scholar
Minton DM, et al. The common marmoset as a translational model of age-related osteoarthritis. Geroscience. 2024;46(3):2827–47.
Article PubMed PubMed Central Google Scholar
Abdul-Azees PA, et al. Changes in oral health during aging in a novel non-human primate model. Geroscience. 2024;46(2):1909–26.
Article CAS PubMed Google Scholar
Hickmott AJ, et al. Age-related changes in hematological biomarkers in common marmosets. Am J Primatol. 2024;86(4):e23589.
Article CAS PubMed Google Scholar
Horvath S, et al. Pan-primate studies of age and sex. Geroscience. 2023;45(6):3187–209.
Article CAS PubMed PubMed Central Google Scholar
Horvath S, et al. DNA methylation age analysis of rapamycin in common marmosets. Geroscience. 2021;43(5):2413–25.
Article CAS PubMed PubMed Central Google Scholar
Fernandez E, et al. Evaluation of the pharmacokinetics of metformin and acarbose in the common marmoset. Pathobiol Aging Age Relat Dis. 2019;9(1):1657756.
Article CAS PubMed PubMed Central Google Scholar
Ross CN, Salmon AB. Aging research using the common marmoset: Focus on aging interventions. Nutr Healthy Aging. 2019;5(2):97–109.
Article PubMed PubMed Central Google Scholar
Sills AM, et al. Long-term treatment with the mTOR inhibitor rapamycin has minor effect on clinical laboratory markers in middle-aged marmosets. Am J Primatol. 2019;81(2):e22927.
Lelegren M, et al. Pharmaceutical inhibition of mTOR in the common marmoset: effect of rapamycin on regulators of proteostasis in a non-human primate. Pathobiol Aging Age Relat Dis. 2016;6:31793.
Ross C, et al. Metabolic consequences of long-term rapamycin exposure on common marmoset monkeys (Callithrix jacchus). Aging (Albany NY). 2015;7(11):964–73.
Comments (0)